Vadim Gurvich received a $137,588 SBIR grant for the project, "Development of a non-addictive analgesic targeting opioid receptor heteromers."
Dr. Gurvich also received a $43,677 contract from NIDA for the project, "(-)-Phenserine Tartrate Purification, Encapsulation, & Testing Support Services."
